Not a good buy right now: trend is decisively bearish (SMA_200 > SMA_20 > SMA_5) with momentum still deteriorating (MACD histogram negative and expanding).
Price is trading below the key pivot (5.08) and sitting near support (S1 4.568); downside risk remains elevated if support breaks toward S2 (4.252).
No Intellectia buy signals today (no AI Stock Picker / no SwingMax), no news catalysts, and fundamentals show ongoing losses with effectively zero revenue in the latest reported quarter.
For an impatient investor, the higher-probability setup is to avoid/exit now rather than trying to catch an oversold bounce ahead of earnings (2026-02-18).
Technical Analysis
Trend: Bearish structure with moving averages stacked down (SMA_200 > SMA_20 > SMA_5), indicating sustained downtrend.
Momentum: MACD histogram at -0.0608 (below zero) and negatively expanding → selling pressure is strengthening, not fading.
RSI: RSI_6 at ~25.5 suggests oversold conditions (bounce is possible), but oversold in a downtrend is not a reliable buy trigger without confirmation.
Key levels: Pivot 5.08 (price below = bearish bias). Immediate support S1 4.568 (current pre-market ~4.62 is sitting on it); next support S2 4.252. Resistance levels: R1 5.592 then R2 5.908.
Pattern-based expectation (similar candlesticks): ~50% chance of only +1.05% next day, but skew turns negative over 1 week (-3.4%) and 1 month (-8.6%), aligning with the downtrend.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Reported put/call ratios are 0.0 (open interest and volume), which usually indicates missing/very thin put activity in the dataset; this limits how much sentiment can be inferred.
Volatility: Historical volatility is very high (~79.18), consistent with a speculative, high-swing microcap profile; without clear IV/volume trend data, options sentiment read is weak.
Technical Summary
Sell
8
Buy
6
Positive Catalysts
can produce a short-lived technical bounce.
Neutral/Negative Catalysts
Strong bearish trend and weakening momentum (MACD worsening) increases probability of support break (4.568 → 4.252).
No news in the past week: lack of near-term catalysts means price action is likely to follow the prevailing downtrend.
Earnings risk (2026-02-18): event volatility is elevated; unfavorable results can accelerate downside.
Trading participation signals are neutral (hedge funds/insiders show no significant recent activity), offering no supportive “smart money” tailwind.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: reported as 0 (0.00% YoY), signaling no demonstrated top-line traction in the period.
Profitability: Net income fell to -$3.121M (down 40.10% YoY) and EPS fell to -2.19 (down 71.34% YoY), indicating losses are worsening.
Overall read: fundamentals do not currently support a momentum reversal thesis; the setup is primarily speculative/technical rather than growth-driven.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, so there is no identifiable recent Wall Street trend to lean on.
Wall Street-style pros (conceptual): potential upside if commercialization ramps and revenue inflects.
Wall Street-style cons (dominant right now): lack of revenue traction in latest quarter, worsening losses, and microcap liquidity/volatility profile.
Wall Street analysts forecast AQMS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AQMS is 12 USD with a low forecast of 12 USD and a high forecast of 12 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast AQMS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AQMS is 12 USD with a low forecast of 12 USD and a high forecast of 12 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 4.220
Low
12
Averages
12
High
12
Current: 4.220
Low
12
Averages
12
High
12
Michael Legg
Speculative Buy
maintain
$7 -> $12
AI Analysis
2025-10-23
Reason
Michael Legg
Price Target
$7 -> $12
AI Analysis
2025-10-23
maintain
Speculative Buy
Reason
Benchmark analyst Michael Legg raised the firm's price target on Aqua Metals to $12 from $7 and keeps a Speculative Buy rating on the shares. Aqua Metals closed a $13M registered direct offering at $11.34 on October 20 through a private placement, notes the analyst, who cites improved liquidity and simplified execution visibility for the firm's raised target.
Benchmark
Mickey Legg
Buy
Reiterates
$3
2025-04-02
Reason
Benchmark
Mickey Legg
Price Target
$3
2025-04-02
Reiterates
Buy
Reason
Benchmark raised the firm's price target on Aqua Metals to $3 from $1 and keeps a Speculative Buy rating on the shares. The company underwent a 1-for-20 reverse split in November and the stock has since settled around the $2.00 price level, notes the analyst. The firm believes production delays and a challenging macro environment have impacted the stock, but views today's stock price as not reflecting the long-term viability and IP valuation, alongside current asset values on the balance sheet, the analyst tells investors.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AQMS
